Literature DB >> 27903687

Shall we call them "telomere-mediated"? Renaming the idiopathic after the cause is found.

Samantha J Merck1,2, Mary Armanios3,4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27903687     DOI： 10.1183/13993003.02115-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

1.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

Review 2.  Extrahematopoietic manifestations of the short telomere syndromes.

Authors:  Kristen E Schratz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  Understanding Interstitial Lung Disease: It's in the Mucus.

Authors:  Burton F Dickey; Jeffrey A Whitsett
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

Review 4.  Cancer and myeloid clonal evolution in the short telomere syndromes.

Authors:  Kristen E Schratz; Mary Armanios
Journal:  Curr Opin Genet Dev       Date:  2020-04-07       Impact factor: 5.578

Review 5.  Long telomeres and cancer risk: the price of cellular immortality.

Authors:  Emily J McNally; Paz J Luncsford; Mary Armanios
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

6.  Airway Telomere Length in Lung Transplant Recipients.

Authors:  John A Mackintosh; Stephanie T Yerkovich; Maxine E Tan; Luke Samson; Peter Ma Hopkins; Daniel C Chambers
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

Review 7.  Idiopathic pulmonary fibrosis: Current and future treatment.

Authors:  Daniel S Glass; David Grossfeld; Heather A Renna; Priya Agarwala; Peter Spiegler; Joshua DeLeon; Allison B Reiss
Journal:  Clin Respir J       Date:  2022-01-10       Impact factor: 1.761

Review 8.  Telomere-mediated lung disease.

Authors:  Jonathan K Alder; Mary Armanios
Journal:  Physiol Rev       Date:  2022-05-09       Impact factor: 46.500

9.  Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.

Authors:  Kristen E Schratz; Valeriya Gaysinskaya; Zoe L Cosner; Emily A DeBoy; Zhimin Xiang; Laura Kasch-Semenza; Liliana Florea; Pali D Shah; Mary Armanios
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.